menu
    • menu

    Company profile for Precigen

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an...
    Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PrecigenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20358 Seneca Meadows Pkwy, Germantown, MD 20876
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://precigen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Precigen Reports Q3 2025 Financial Results And Business Updates
    Precigen Reports Q3 2025 Financial Results And Business Updates

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/precigen-reports-third-quarter-2025-financial-results-and-business-updates-302614965.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Precigen To Unveil Q3 2025 Financials & Business Updates
    Precigen To Unveil Q3 2025 Financials & Business Updates

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/precigen-to-announce-third-quarter-2025-financial-results-and-provide-business-updates-on-november-13-302606625.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Precigen Reveals PAPZIMEOS, Sustains Durable Responses
    Precigen Reveals PAPZIMEOS, Sustains Durable Responses

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/precigen-announces-long-term-follow-up-results-highlighting-ongoing-durable-complete-responses-after-treatment-with-papzimeos-the-first-and-only-fda-approved-therapy-for-adults-with-recurrent-respiratory-papillomatosis-302581497.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    Precigen Announces Up to $125 Million Non-Dilutive Financing
    Precigen Announces Up to $125 Million Non-Dilutive Financing

    03 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/precigen-announces-up-to-125-million-non-dilutive-financing-302544623.html

    PR NEWSWIRE
    03 Sep 2025
    Share Share
    Precigen Joins Cantor and H.C. Wainwright Virtual Fireside Chats
    Precigen Joins Cantor and H.C. Wainwright Virtual Fireside Chats

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/precigen-to-participate-in-upcoming-virtual-fireside-chats-hosted-by-cantor-and-hc-wainwright-302537276.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share
    US FDA Approves First Therapy for Rare Respiratory Disease
    US FDA Approves First Therapy for Rare Respiratory Disease

    18 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/precigen-announces-full-fda-approval-of-papzimeos-zopapogene-imadenovec-drba-the-first-and-only-approved-therapy-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis-302530957.html

    PR NEWSWIRE
    18 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search